Literature DB >> 23321723

Association of body fat with inflammation in peritoneal dialysis.

Andresa Marques de Mattos1, Paula Payão Ovidio, Alceu Afonso Jordão, José Abrão Cardeal da Costa, Paula Garcia Chiarello.   

Abstract

Peritoneal dialysis (PD) frequently leads to body weight gain, which appears to be a potential cause of the chronic inflammation frequently present in these patients. The consequences of this inflammation are impaired nutritional status, accelerated atherosclerosis, and increased mortality. To assess the association between inflammation and body fat in female patients treated with PD. Nineteen female patients on PD for at least 6 months with no infectious complications or malignant or acute inflammatory diseases. Nutritional status was determined by measuring weight, height, body mass index (BMI), waist (WC), and mid-arm circumferences (MAC), mid-arm muscle area, and tricipital fold (TCF). Bioelectrical impedance (BIA) was used to determine body composition. Biochemical evaluation included the determination of serum albumin, urea, creatinine, and C-reactive protein (CRP). The glucose absorbed from the dialysis solution was quantitated. According to BMI, two patients were classified as malnourished and ten as overweight/obese. Sixteen individuals had high WC measurements and 12 had excess body fat (BF) as measured by BIA. High CRP levels were observed in 12 patients, who had higher WC, MAC, BMI, TCF, and BF measurements compared to non-inflamed patients. Positive associations were detected between CRP and BMI, MAC, WC, and TCF. Associations between BF and CRP suggest that adiposity may be a potent exacerbating factor of inflammation in this population, especially visceral fat. Thus, obesity may be considered to be one more factor responsible for the early atherosclerosis and high cardiovascular mortality observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23321723     DOI: 10.1007/s10753-013-9593-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

1.  Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD.

Authors:  Luis F Ramos; Ayumi Shintani; T Alp Ikizler; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

2.  NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation.

Authors: 
Journal:  Am J Kidney Dis       Date:  1997-09       Impact factor: 8.860

3.  Changes in body composition parameters in patients on haemodialysis and peritoneal dialysis.

Authors:  Maria Cristina Di-Gioia; Paloma Gallar; Isabel Rodríguez; Nuria Laso; Ramiro Callejas; Olimpia Ortega; Juan C Herrero; Ana Vigil
Journal:  Nefrologia       Date:  2012       Impact factor: 2.033

4.  Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism.

Authors:  Xin Wang; Jonas Axelsson; Louise Nordfors; A Rashid Qureshi; Carla Avesani; Peter Barany; Martin Schalling; Olof Heimbürger; Bengt Lindholm; Peter Stenvinkel
Journal:  Nephrol Dial Transplant       Date:  2006-09-17       Impact factor: 5.992

Review 5.  Inflammation in peritoneal dialysis.

Authors:  Kar Neng Lai; Joseph C K Leung
Journal:  Nephron Clin Pract       Date:  2010-05-12

6.  Truncal fat mass as a contributor to inflammation in end-stage renal disease.

Authors:  Jonas Axelsson; Abdul Rashid Qureshi; Mohammed E Suliman; Hirokazu Honda; Roberto Pecoits-Filho; Olof Heimbürger; Bengt Lindholm; Tommy Cederholm; Peter Stenvinkel
Journal:  Am J Clin Nutr       Date:  2004-11       Impact factor: 7.045

7.  The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study.

Authors:  Marcelo M Nascimento; Roberto Pecoits-Filho; A Rashid Qureshi; Shirley Y Hayashi; Roberto C Manfro; Maria A Pachaly; Luciana Renner; Peter Stenvinkel; Bengt Lindholm; Miguel C Riella
Journal:  Nephrol Dial Transplant       Date:  2004-11       Impact factor: 5.992

8.  Nutritional requirements and actual dietary intake of continuous ambulatory peritoneal dialysis patients.

Authors:  Vincent C Chow; Rose M Yong; Alice L Li; Chi-wai Lee; Eva H Ho; Ching-kit Chan; Stanley H Lo; Stephen K Mo; Kin-shing Wong
Journal:  Perit Dial Int       Date:  2003-12       Impact factor: 1.756

Review 9.  Peritoneal adipocytes and their role in inflammation during peritoneal dialysis.

Authors:  Kar Neng Lai; Joseph C K Leung
Journal:  Mediators Inflamm       Date:  2010-05-05       Impact factor: 4.711

10.  Waist-to-Hip Ratio, Cardiovascular Outcomes, and Death in Peritoneal Dialysis Patients.

Authors:  Winnie S Su; Catherine M Clase; K Scott Brimble; Peter J Margetts; Trevor J Wilkieson; Azim S Gangji
Journal:  Int J Nephrol       Date:  2010-07-05
View more
  5 in total

1.  Dyslipidemia and Intraperitoneal Inflammation Axis in Peritoneal Dialysis Patients: A Cross-Sectional Pilot Study.

Authors:  Natalia Stepanova; Victoria Driianska; Svitlana Savchenko
Journal:  Kidney Dis (Basel)       Date:  2019-11-06

2.  Systemic Action of Inflammatory Mediators in Patients with Essential Hypertension and Diastolic Chronic Heart Failure: A Clinical Pathophysiological Study.

Authors:  Anton V Barsukov; Alla Yu Seidova; Ksenia A Shcherbakova; Marina S Black; Alexander E Korovin; Leonid P Churilov; Dmitry V Tovpeko
Journal:  Pathophysiology       Date:  2020-12-12

3.  Dissecting the mechanisms of left ventricular diastolic dysfunction and inflammation in peritoneal dialysis patients.

Authors:  Cho-Kai Wu; Yin-Tsen Huang; Heng-Hsu Lin; Chung-Yi Yang; Yu-Chung Lien; Jen-Kuang Lee; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

Review 4.  Metabolic syndrome and obesity in peritoneal dialysis.

Authors:  Wai Kei Lo
Journal:  Kidney Res Clin Pract       Date:  2016-01-13

5.  Association between Dyslipidemia and Peritoneal Dialysis Technique Survival.

Authors:  Natalia Stepanova; Olena Burdeyna
Journal:  Open Access Maced J Med Sci       Date:  2019-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.